Announcing the new Restylane Eyelight for tear trough rejuvenation
When a patient sits in your chair looking at him or herself in the mirror, how often is it that the tired eyes looking back at them are their main cause for concern? Many just want to feel that their eyes reflect how they feel inside and don’t let them down. According to a recent survey, many people think their tired-looking eyes don’t match how they feel. Others think it makes them feel older than they are.1
As part of the normal course of ageing, patients present with the deterioration of the skin in the delicate eye area which in turn can lead to hollowing, drooping, lines and wrinkles. The volume loss under the eyes can also create unflattering light refraction leading to dark circles. Whether it’s lifestyle choices, environmental factors, or simply the path of time, tear trough treatment can tackle many undereye complaints to produce a positive patient outcome and an overall facial refresh.
Tried and tested technology
New from Galderma, Restylane Eyelight is a hyaluronic acid filler formulated specifically to treat the eye area using the trusted NASHA technology with the right gel properties for treating the tear trough.2,3 The NASHA cross-linking technology produces firmer gels that are ideal for the tear trough area to treat tired-looking eyes.2,3 This Restylane technology has more than 25 years of use by healthcare practitioners.4 Over 50 million treatments with Restylane fillers have been performed to date worldwide, including tear trough treatments to combat tired-looking eyes.4
Eye-opening statistics
Restylane Eyelight was recently investigated in a clinical study comprising women between 23 and 68 years of age.2 The study showed that:
- 83% were satisfied or extremely satisfied with their tear trough treatment. Remember that in many cases, tired-looking eyes cannot be solved with a filler under the eye only. Despite that, the overall satisfaction in the study was very high.
- 82.9% still saw a noticeable improvement 6.5 months after treatment. As has been explained, your body will gradually break down the tear tough filler – how fast differs from person to person. The study clearly shows, however, that overall, the effect is long-lasting.
- 94.3% would recommend the treatment to a friend and repeat the treatment.
Lasting power
How long the effects of Eyelight last varies from person to person, but 83% of patients reported durable results at least six months after treatment.2
Dr Munir Somji, founder of Dr MediSpa, says, “Improving tired looking eyes can often be the single most impactful tweak we can offer patients and I am treating more tear troughs in my clinics than ever before. The rise in anxiety levels and sleepless nights resulting from the pandemic, increased working hours, and the digital bathroom mirror we call Zoom, may all have a hand in this upward trend. But the best non-invasive treatment for hollowing under the eyes, however, remains the same. Expertly injected tear trough filler helps to correct hollowing, reducing shadowing under the eyes to give a brighter more well rested appearance. The new Restylane Eyelight provides the ideal tool to deliver safe, reliable, lasting results. The consistency is perfect to sit in the intended treatment zone with little to no spread. More importantly it has low hygroscopic behaviour reducing the chances of periorbital oedema. It’s exciting to have this new filler as part of our library of offerings; I have confidence in the technology as it has over 25 years of history in the market, the safety profile is good and the studies are very promising.”
Discover the full range
To discover Restylane Eyelight and the full Restylane range, contact your Galderma representative for training via the GAIN (Galderma Aesthetic Injector Network) Program and marketing support: [email protected]
Restylane and the full Galderma portfolio is available is exclusively available with Medfx: www.medfx.co.uk
Adverse events should be reported. For the UK, Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for Yellow Card in the Google Play or Apple App Store.
For Ireland, Suspected adverse events can be reported via HPRA Pharmacovigilance, Website: www.hpra.ie; Adverse events should also be reported to Galderma (UK) Ltd,
Email: [email protected] Tel: +44 (0) 300 3035674
